Dr. Spears is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3415 American River Dr
Ste C
Sacramento, CA 95864Phone+1 916-692-8480Fax+1 916-692-8545
Summary
- ABIM Board Certified Internal Medicine 1982 and Medical Oncology 1985 and Board Eligible Hematology 1985, Chairman Dignity Health Mercy General Hospital Sacramento CA Cancer Committee 2005-2015, Cancer Center 2010-2016. Research see www.cpspears.com and www.fibons.com (under construction). Research areas: tumor biopsy thymidylate synthase and CoFactor pharmcodynamics. Sequential Slide Video-Microscopy (SSVM). Fibonacci discrete mathematics. Alkylating Agent Swain-Scott kinetics. Volume and Area Doubling Rulers (product launch 2023).
Education & Training
Good Samaritan HospitalFellowship, Hematology and Medical Oncology, 1983 - 1984- USC Comprehensive Cancer CenterResearch Scholar - with Prof. Charles Heidelberger, Chemistry and Biochemistry, 1978 - 1983
- USC Comprehensive Cancer CenterOncology, NCI NIH Training Grant Fellowships, 1974 - 1976
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1973 - 1974- US Public Health Service NASA Cardiology, Bedrest as an Analog of the Weightless State, 1971 - 1973
- US Public Health Service HospitalInternship, Internal Medicine, 1970 - 1971
State University of New York Downstate Medical Center College of MedicineClass of 1970- Queens College, CUNYBA, Chemistry-Biology, Cum Laude, 1962 - 1966
Certifications & Licensure
CA State Medical License 1972 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Consultant of the Year Family Practice Residency Program Dignity Health Sacramento, 2003, 2008-2009
Clinical Trials
- Clinical Trial in Patients With Metastatic Colorectal Cancer Start of enrollment: 2004 Apr 01
- Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis. Start of enrollment: 2018 Aug 28
Publications & Presentations
Journal Articles
- CP Spears CVSpears, CP, PNAS ACS
Authored Content
- CP Spears C.V.December 2022
Grant Support
- Biochemistry and Pathology of FluorouracilNIH NCI1984–1997
Industry Relationships
- Clinical Director, Eli LillyAlimta Team 20 Trials including Registration Trials with addition of Folate1999 - 2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
